The global postpartum hemorrhage (pph) devices market was valued at $797.32 million in 2020, and is projected to reach $1.3 billion by 2030, growing at a CAGR of 5.3% from 2021 to 2030.
The most frequent type of obstetric haemorrhage is postpartum haemorrhage (PPH), which is one of the main causes of mother mortality. Blood loss during vaginal or caesarean deliveries is known as PPH. PPH is categorised according to blood loss. Blood loss of less than 500 ml is referred to as primary PPH, and blood loss of more than 500 ml is secondary PPH. Due to their focus on treating uterine diseases and issues with uterine contractions, modern PPH treatment devices outperform conventional treatments. PPH devices are second-line interventional tools that are used as prefilled injectable systems, uterine balloon tamponades, and non-pneumatic anti-shock garments. These gadgets work well to block blood flow and stabilise the patient’s condition until more substantial care is given.
Postpartum Hemorrhage Treatment Devices Market: Overview
This report’s market overview includes information from a range of sources, including government agencies, trade and industry organisations, well-established businesses, industry brokers, and other relevant regulatory and non-regulatory authorities. These companies’ data validate the Postpartum Hemorrhage (PPH) Treatment Devices market research study, assisting clients in making more informed choices. Additionally, the data in this research offers a modern comprehension of industry dynamics.
Market Growth Factors:
Rise in Complications Like Obstetric Hemorrhage:- The market for postpartum haemorrhage devices is expanding as complications like acute postpartum haemorrhage are becoming more common. Obstetric haemorrhage is the most frequent and harmful birth-related complication.
Growing Investment in Healthcare Sector in Developed and Developing Countries: – The healthcare systems of developing nations like China and India are receiving significant investment from their respective governments. For instance, it was predicted that the Indian health tech market would be valued $1.9 billion in 2020. With a CGAR of 39%, it is expected to reach $5 billion by 2023. In 2018, the Indian digital healthcare market was valued at USD 1.50 billion, and by 2024, it is anticipated to reach USD 6.26 billion. The market for postpartum haemorrhage devices is projected to benefit from the growth of the healthcare industry. The healthcare industry is being modernised and expanded by governments everywhere, including in industrialised nations like the United States.
Request a sample copy of the report – https://healthcaremarketreports.com/sample-request/postpartum-hemorrhage-treatment-devices-market/68879/
Postpartum Hemorrhage Treatment Devices Market: Segmentation
Key Players:
- Ge Healthcare
- Davol
- 3rd Stone Design
- Utah Medical Products
- Program for Appropriate Technology In Health (Path)
- Teleflex Incorporated
- Becton Dickinson
- Cook Medical
- Bactiguard
- Bard
- By Types:
- Uterine Balloon Tamponade
- Uniject Prefilled Injection System
- Other
By Applications:
- Hospitals
- Clinics
- Other
By Regions:
- North America
- Europe
- China
- Japan
- Middle East and Africa
- South America
- India
- South Korea
- Southeast Asia
- Others
COVID-19 Impact:
The COVID-19 pandemic wreaked havoc on the health and economy of people all across the world. Along with affecting individual careers and lives, it has an effect on large economies and enterprises. Millions of people died tragically as a result of the pandemic all across the world. The stress of keeping income levels at pre-COVID levels has replaced development prospects as firms shift their attention away from those prospects and toward putting extraordinary precautions in place to prevent the negative effects of the COVID-19 pandemic. The COVID-19 epidemic is anticipated to increase demand for postpartum bleeding devices. By increasing the likelihood of pregnancy issues such postpartum haemorrhage, such as Covid-19 infection, the market is able to expand because of the rise in PPH patients.
FAQs:
- What is the driving factor for the growth of the Postpartum Hemorrhage Treatment Devices market?
- How will the COVID-19 pandemic impact the demand and consumption of the Postpartum Hemorrhage Treatment Devices market?
- What is the major application area of this market?
- Who are the Postpartum Hemorrhage Treatment Devices manufacturers across the globe?
- Which geographical location is dominant in this market?
- Which are the top industry players in the Postpartum Hemorrhage Treatment Devices market?
To Buy This Report Click On Given Link:- https://healthcaremarketreports.com/purchase/postpartum-hemorrhage-treatment-devices-market/68879/?license=single
About Us:
The healthcare industry is surely facing disruptions with global economies giving high importance to individual health. In this scenario, we expect our clients to get deep insights to power their innovations in the right direction. We have been keeping a close watch on the changes and modifications happening in the healthcare domain. As per our understanding, these alterations are active and unexampled.
Contact Us:
Healthcare Market Reports
sales@healthcaremarketreports.com
+1(929)-450-2887